Evidence map›Paper›PMID 33117167›Full record

ArticleFrontiers in pharmacology2020

L-Carnitine Mitigates Oxidative Stress and Disorganization of Cytoskeleton Intermediate Filaments in Cisplatin-Induced Hepato-Renal Toxicity in Rats.

Ashraf Elkomy, Ehab Yahya Abdelhiee, Sabreen Ezzat Fadl, Mahmoud Abdelghaffar Emam, Fatma Abdel-Monem Gad, Adham Sallam, Saud Alarifi, Mohamed M Abdel-Daim, Mohamed Aboubakr

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Testicular toxicity of cisplatin in rats: ameliorative effect of lycopene and N-acetylcysteine.Environmental science and pollution research international · 2022
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ashraf ElkomyDepartment of Pharmacology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
Ehab Yahya AbdelhieeDepartment of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Matrouh University, Matrouh, Egypt.
Sabreen Ezzat FadlDepartment of Biochemistry, Faculty of Veterinary Medicine, Matrouh University, Matrouh, Egypt.
Mahmoud Abdelghaffar EmamDepartment of Histology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
Fatma Abdel-Monem GadDepartment of Clinical Pathology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
Adham SallamDepartment of Pharmacology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
Saud AlarifiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mohamed M Abdel-DaimDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Mohamed AboubakrDepartment of Pharmacology, Faculty of Veterinary Medicine, Benha University, Toukh, Egypt.
Benha University · EGEgypt Nanotechnology Center · EGKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin (CP) is one of the most active medications in cancer treatment and has some adverse effects such as hepatotoxicity and nephrotoxicity. The present research was planned to determine the protective effects of L-carnitine (LC) against CP-induced hepato-renal oxidative stress in rats,

Indexed as

cisplatinhepato-renal toxicityintermediate filamentsL-carnitineoxidative stress

Identifiers

PMID33117167
PMCPMC7552923
OpenAlexW3091516068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.